Public Health

Low Sex Drive While on Ozempic: What Does Research Say?

Brianne Smith, DNP, PhD
Brianne Smith, DNP, PhD22 May 2024
Reviewed and Fact Checked ✔️

GLP-1 is a hormone produced in the gut that helps regulate appetite and blood sugar levels. Medications that mimic GLP-1 (known as GLP-1 receptor agonists) are used to treat obesity and type 2 diabetes. GLP-1 like Semaglutide and Tirzepatide has been shown to reduce reward-seeking behaviors. For many of us, that means becoming indifferent to sweet and fatty foods, leading to significant weight loss. It is possible that the same mechanism behind weight loss can spill over to our sex life. 

Animal Study Shows That Ozempic May Reduce Sex Drive

In a study by Vestlund and Jerlhag (2020), the researchers found that when they injected a GLP-1 receptor agonist (a substance that mimics the effects of GLP-1) called exendin-4 into specific areas of the brain in male mice, it reduced their sexual behaviors. 

In simple terms, this means that activating GLP-1 (Ozempic, Mounjaro, Wegovy) could affect parts of the brain leading to a decrease in the male mice's interest in sexual activities. The study suggests that GLP-1 might play a role in regulating not just food intake and body weight, but also sexual behavior in males.

Health Image

Get affordable doctor copay without paying insurance premiums

Join 39,000 people and get Mira, the best alternative to traditional insurance. Enroll and use immediately. Plans start at only $45/mo.

Brianne Smith, DNP, PhD

Brianne Smith, DNP, PhD, is a public health researcher with a focus on improving patient outcomes through evidence-based practices and clinical research. She holds dual doctorates in Nursing Practice and Healthcare Research, and specializes in advanced patient care management and educational advocacy.

Get Health BenefitsGet Lab TestsTalk Therapy
Get ObamaCare
> See Plans